1bf9: Difference between revisions

New page: left|200px<br /> <applet load="1bf9" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bf9" /> '''N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTO...
 
No edit summary
Line 1: Line 1:
[[Image:1bf9.gif|left|200px]]<br />
[[Image:1bf9.gif|left|200px]]<br /><applet load="1bf9" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1bf9" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1bf9" />
caption="1bf9" />
'''N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES'''<br />
'''N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES'''<br />


==Overview==
==Overview==
Blood coagulation is initiated by Ca(2+)-dependent binding of coagulation, factor VIIa (FVIIa) to its cofactor, tissue factor (TF). The TF:FVIIa, complex activates factors IX and X, ultimately leading to the formation of, thrombin and the coagulation of blood. FVII consists of an N-terminal, gamma-carboxyglutamic-acid-containing (Gla) domain followed by two, epidermal growth factor (EGF) like domains, the first of which can bind, one Ca2+ ion (Kd approximately 150 microM) and a C-terminal serine, protease domain. Using 1H nuclear magnetic resonance spectroscopy, we have, determined the solution structure of a synthetic N-terminal EGF-like, domain (EGF1) of human FVII (residues 45-85) in the absence of Ca2+. A, comparison of this structure of apo EGF1 with the Ca(2+)-bound EGF1 in the, complex of FVIIa and TF [Banner, D. W., et al. (1996) Nature 380, 41-46], suggests that the structural changes in the EGF1 domain upon Ca2+ binding, are minor and are concentrated near the Ca(2+)-binding site, which is, facing away from the TF interaction surface. Amino acid side chains that, are crucial for the binding of FVII to TF show a similar conformation in, both structures and are therefore unlikely to directly influence the, Ca(2+)-dependent binding of FVII to TF. As Ca2+ binding to EGF1 does not, lead to a conformational change in the residues constituting the, interaction surface for binding to TF, our results are consistent with the, idea that the altered orientation between the Gla and EGF1 domains that, result from Ca2+ binding is responsible for the increased affinity of, FVII/FVIIa for TF.
Blood coagulation is initiated by Ca(2+)-dependent binding of coagulation factor VIIa (FVIIa) to its cofactor, tissue factor (TF). The TF:FVIIa complex activates factors IX and X, ultimately leading to the formation of thrombin and the coagulation of blood. FVII consists of an N-terminal gamma-carboxyglutamic-acid-containing (Gla) domain followed by two epidermal growth factor (EGF) like domains, the first of which can bind one Ca2+ ion (Kd approximately 150 microM) and a C-terminal serine protease domain. Using 1H nuclear magnetic resonance spectroscopy, we have determined the solution structure of a synthetic N-terminal EGF-like domain (EGF1) of human FVII (residues 45-85) in the absence of Ca2+. A comparison of this structure of apo EGF1 with the Ca(2+)-bound EGF1 in the complex of FVIIa and TF [Banner, D. W., et al. (1996) Nature 380, 41-46] suggests that the structural changes in the EGF1 domain upon Ca2+ binding are minor and are concentrated near the Ca(2+)-binding site, which is facing away from the TF interaction surface. Amino acid side chains that are crucial for the binding of FVII to TF show a similar conformation in both structures and are therefore unlikely to directly influence the Ca(2+)-dependent binding of FVII to TF. As Ca2+ binding to EGF1 does not lead to a conformational change in the residues constituting the interaction surface for binding to TF, our results are consistent with the idea that the altered orientation between the Gla and EGF1 domains that result from Ca2+ binding is responsible for the increased affinity of FVII/FVIIa for TF.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1BF9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1BF9 OCA].  
1BF9 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_VIIa Coagulation factor VIIa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.21 3.4.21.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BF9 OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Drakenberg, T.]]
[[Category: Drakenberg, T.]]
[[Category: Finn, B.E.]]
[[Category: Finn, B E.]]
[[Category: Forsen, S.]]
[[Category: Forsen, S.]]
[[Category: Gippert, G.P.]]
[[Category: Gippert, G P.]]
[[Category: Muranyi, A.]]
[[Category: Muranyi, A.]]
[[Category: Stenflo, J.]]
[[Category: Stenflo, J.]]
Line 29: Line 28:
[[Category: serine protease]]
[[Category: serine protease]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:09:06 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:54:38 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA